
Indian pharmaceutical vivimed poised to land in spain via purchase of two facilities in barcelona.
Business Investments
03 Oct 2011
Indian group vivimed has purchased industrial property in catalonia, with a view to expanding throughout europe, as it aims to become one of the world’s major suppliers of compounds to pharmaceutical companies. until now, it has centred on creation of compounds for dental hygiene products, sun creams and skin and hair care ranges.
in order to further its growth on the continent, the firm is tying up the takeover of uquifa, a major supplier of compounds to manufacturers of generic drugs produced by its two barcelona factories and another in mexico. the acquisition will provide the firm with a leg-up into the area of compounds which form the basis of medicaments that treat ulcers as well as anti-depressants. if the deals finally go through, there is every hope that the 390 employees on the payroll at uquifa will keep their jobs .
source: expansión, 21/9/2011
Related News and Success stories.
-
21 Feb 2025
Foundever establishes global AI innovation center in Barcelona
-
20 Feb 2025
Success Case: Tech giant Oracle expands in Barcelona with a new European Health Hub
-
12 Feb 2025
Henkel strengthens European operations with a new Barcelona hub
-
10 Feb 2025
Success Case: Bayer Barcelona, a Strategic Hub for Innovation and Growth